Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABALOPARATIDE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 11 adverse event reports in the FDA FAERS database where ABALOPARATIDE was used for Psoriasis.

Most Reported Side Effects for ABALOPARATIDE

Side Effect Reports % Deaths Hosp.
Headache 4,048 17.3% 0 92
Nausea 3,134 13.4% 1 84
Dizziness 3,005 12.9% 0 99
Fatigue 2,637 11.3% 0 63
Heart rate increased 2,092 9.0% 0 40
Palpitations 1,730 7.4% 0 50
Arthralgia 1,711 7.3% 0 41
Bone pain 1,360 5.8% 0 26
Back pain 1,229 5.3% 0 37
Pain 1,191 5.1% 0 48
Product dose omission issue 1,006 4.3% 0 78
Injection site bruising 946 4.1% 0 20
Product dose omission 938 4.0% 1 64
Product quality issue 914 3.9% 1 26
Pain in extremity 912 3.9% 0 26

Other Indications for ABALOPARATIDE

Osteoporosis postmenopausal (7,932) Senile osteoporosis (7,272) Osteoporosis (4,420) Product used for unknown indication (3,174) Osteoporotic fracture (658) Pathological fracture (191) Illness (179) Rheumatoid arthritis (130) Osteoarthritis (71) Bone density abnormal (70)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

ABALOPARATIDE Full Profile All Psoriasis Drugs ABALOPARATIDE Demographics ABALOPARATIDE Timeline